Difference between revisions of "Enoximone"
From Self-sufficiency
m (Stub sorting and placement of stub template(s)) |
m (1 revision) |
(No difference)
|
Latest revision as of 15:48, 19 September 2010
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (October 2006) |
File:Enoximone.svg | |
Systematic (IUPAC) name | |
---|---|
4-methyl-5-{[4-(methylsulfanyl)phenyl]carbonyl}-2,3-dihydro-1H-imidazol-2-one | |
Clinical data | |
Routes of administration | Intravenous |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50% (oral) |
Protein binding | 85% |
Metabolism | Hepatic oxidation |
Biological half-life | 4 to 10 hours |
Excretion | Renal (60 to 70%) |
Identifiers | |
CAS Number | 77671-31-9 |
ATC code | C01CE03 (WHO) |
PubChem | CID 53708 |
Chemical data | |
Formula | C12H12N2O2S |
Molar mass | 248.302 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
(verify) |
Enoximone (INN, trade name Perfan) is an imidazole phosphodiesterase inhibitor. It is used in the treatment of congestive heart failure. Selective for phosphodiesterase 3
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from October 2006
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- 2Fix
- Cardiac stimulants
- Imidazoles
- Thioethers
- Ketones
- Ureas
- Lactams
- PDE3 inhibitors
- Cardiovascular system drug stubs